Protara Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2011 | — | $-72.7M | $3.3M |
| Dec 2012 | — | $-86.7M | $2.4M |
| Sep 2013 | — | — | $6.9M |
| Dec 2013 | — | $-100.5M | $2.8M |
| Mar 2014 | — | — | $3.6M |
| Jun 2014 | — | — | $8.6M |
| Sep 2014 | — | $-116.6M | $3.2M |
| Dec 2014 | — | $82.5M | $68.8M |
| Mar 2015 | — | $78.3M | $9.8M |
| Jun 2015 | — | $73.8M | $16.8M |
| Sep 2015 | — | $69.0M | $36.0M |
| Dec 2015 | — | $63.4M | $40.0M |
| Mar 2016 | — | $57.8M | $24.1M |
| Jun 2016 | — | $50.9M | $34.2M |
| Sep 2016 | — | $44.5M | $26.7M |
| Dec 2016 | — | $38.4M | $36.4M |
| Mar 2017 | — | $33.0M | $34.1M |
| Jun 2017 | — | $29.5M | $18.4M |
| Sep 2017 | — | $39.5M | $20.0M |
| Dec 2017 | — | $34.7M | $21.2M |
| Mar 2018 | — | $29.5M | $25.4M |
| Jun 2018 | — | $25.6M | $12.5M |
| Sep 2018 | — | $24.9M | $18.2M |
| Dec 2018 | — | $4.8M | $19.4M |
| Mar 2019 | — | $3.3M | $16.8M |
| Jun 2019 | — | $2.0M | $10.8M |
| Sep 2019 | — | $284.9K | $9.3M |
| Dec 2019 | — | $-2.1M | $564.0K |
| Mar 2020 | — | $64.7M | $36.1M |
| Jun 2020 | — | $59.4M | $30.0M |
| Sep 2020 | — | $194.6M | $165.9M |
| Dec 2020 | — | $199.2M | $168.6M |
| Mar 2021 | — | $188.1M | $58.2M |
| Jun 2021 | — | $178.4M | $46.8M |
| Sep 2021 | — | $170.4M | $40.7M |
| Dec 2021 | — | $161.9M | $35.7M |
| Mar 2022 | — | $152.2M | $25.4M |
| Jun 2022 | — | $145.5M | $33.8M |
| Sep 2022 | — | $139.2M | $47.5M |
| Dec 2022 | — | $102.1M | $24.1M |
| Mar 2023 | — | $94.8M | $21.0M |
| Jun 2023 | — | $85.2M | $34.0M |
| Sep 2023 | — | $77.0M | $33.8M |
| Dec 2023 | — | $68.3M | $39.6M |
| Mar 2024 | — | $58.4M | $52.2M |
| Jun 2024 | — | $92.1M | $89.6M |
| Sep 2024 | — | $81.8M | $51.8M |
| Dec 2024 | — | $167.1M | $162.8M |
| Mar 2025 | — | $158.5M | $91.5M |
| Jun 2025 | — | $144.4M | $31.5M |
| Sep 2025 | — | $132.3M | $12.6M |
| Dec 2025 | — | $196.4M | $49.7M |
| Mar 2026 | — | $181.2M | $14.7M |
| Jun 2026 | — | $161.3M | $17.1M |